306 related articles for article (PubMed ID: 15221291)
1. Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay.
Dunkelmann S; Wolf R; Koch A; Kittner C; Groth P; Schuemichen C
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1428-34. PubMed ID: 15221291
[TBL] [Abstract][Full Text] [Related]
2. Distinction between autoimmune and non-autoimmune hyperthyroidism by determination of TSH-receptor antibodies in patients with the initial diagnosis of toxic multinodular goiter.
Wallaschofski H; Orda C; Georgi P; Miehle K; Paschke R
Horm Metab Res; 2001 Aug; 33(8):504-7. PubMed ID: 11544566
[TBL] [Abstract][Full Text] [Related]
3. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
Meller J; Jauho A; Hüfner M; Gratz S; Becker W
Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
[TBL] [Abstract][Full Text] [Related]
4. Incidence of radioiodine induced Graves' disease in patients with multinodular toxic goiter.
Meller J; Siefker U; Hamann A; Hüfner M
Exp Clin Endocrinol Diabetes; 2006 May; 114(5):235-9. PubMed ID: 16804797
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
6. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
7. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves' disease.
Tozzoli R; D'Aurizio F; Villalta D; Giovanella L
Clin Chem Lab Med; 2017 Jan; 55(1):58-64. PubMed ID: 27331310
[TBL] [Abstract][Full Text] [Related]
9. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
10. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
11. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
13. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
[TBL] [Abstract][Full Text] [Related]
14. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
Zöphel K; Roggenbuck D; von Landenberg P; Wunderlich G; Grüning T; Kotzerke J; Lackner KJ; Rees Smith B
Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
[TBL] [Abstract][Full Text] [Related]
15. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
16. Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease.
Zimmermann-Belsing T; Nygaard B; Rasmussen AK; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):173-7. PubMed ID: 11834425
[TBL] [Abstract][Full Text] [Related]
17. Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease.
Alnaqdy A; Al-Maskari M
Med Princ Pract; 2005; 14(4):209-12. PubMed ID: 15961927
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
19. Continuously increasing sensitivity over three generations of TSH receptor autoantibody assays.
Zöphel K; Roggenbuck D; Wunderlich G; Schott M
Horm Metab Res; 2010 Nov; 42(12):900-2. PubMed ID: 20925015
[TBL] [Abstract][Full Text] [Related]
20. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis.
Tozzoli R; Bagnasco M; Giavarina D; Bizzaro N
Autoimmun Rev; 2012 Dec; 12(2):107-13. PubMed ID: 22776786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]